AR021054A1 - ANALGESIC REGIME - Google Patents
ANALGESIC REGIMEInfo
- Publication number
- AR021054A1 AR021054A1 ARP990105524A ARP990105524A AR021054A1 AR 021054 A1 AR021054 A1 AR 021054A1 AR P990105524 A ARP990105524 A AR P990105524A AR P990105524 A ARP990105524 A AR P990105524A AR 021054 A1 AR021054 A1 AR 021054A1
- Authority
- AR
- Argentina
- Prior art keywords
- tramadol
- regimen
- analgesic regime
- analgesic
- regime
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe un régimen para la administracion de tramadol para el tratamiento de analgesia. El régimen implica una velocidad de titulacion inicial máslenta de tramadol, que da como resultado un porcentaje significativamente reducido de interrupcionesde la terapia debido a una menor incidencia y severidad delos efectos colaterales.A regimen for the administration of tramadol for the treatment of analgesia is described. The regimen implies a slower initial titration rate of tramadol, which results in a significantly reduced percentage of therapy interruptions due to a lower incidence and severity of side effects.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10656798P | 1998-11-02 | 1998-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021054A1 true AR021054A1 (en) | 2002-06-12 |
Family
ID=22312128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990105524A AR021054A1 (en) | 1998-11-02 | 1999-11-01 | ANALGESIC REGIME |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1126834A1 (en) |
| CN (1) | CN1346266A (en) |
| AR (1) | AR021054A1 (en) |
| AU (1) | AU763273B2 (en) |
| BR (1) | BR9914981A (en) |
| CA (1) | CA2348907A1 (en) |
| CZ (1) | CZ20011535A3 (en) |
| EA (1) | EA003557B1 (en) |
| HR (1) | HRP20010311A2 (en) |
| HU (1) | HUP0104260A3 (en) |
| NO (1) | NO20012133L (en) |
| PL (1) | PL348808A1 (en) |
| WO (1) | WO2000025769A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
| EP1905435A3 (en) * | 2003-03-11 | 2008-05-14 | Euro-Celtique S.A. | Titration dosing regimen for controlled release tramadol |
| US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
| CA2616416A1 (en) | 2005-09-09 | 2007-05-03 | Labopharm, Inc. | Trazodone composition for once a day adminisitiation |
| AU2017226830B2 (en) * | 2016-02-29 | 2021-06-24 | Grünenthal GmbH | Titration of cebranopadol |
-
1999
- 1999-10-12 EP EP99951876A patent/EP1126834A1/en not_active Withdrawn
- 1999-10-12 HU HU0104260A patent/HUP0104260A3/en unknown
- 1999-10-12 BR BR9914981-8A patent/BR9914981A/en not_active IP Right Cessation
- 1999-10-12 EA EA200100501A patent/EA003557B1/en not_active IP Right Cessation
- 1999-10-12 PL PL99348808A patent/PL348808A1/en not_active Application Discontinuation
- 1999-10-12 CN CN99814987A patent/CN1346266A/en active Pending
- 1999-10-12 CA CA002348907A patent/CA2348907A1/en not_active Abandoned
- 1999-10-12 CZ CZ20011535A patent/CZ20011535A3/en unknown
- 1999-10-12 AU AU64224/99A patent/AU763273B2/en not_active Ceased
- 1999-10-12 WO PCT/US1999/023513 patent/WO2000025769A1/en not_active Application Discontinuation
- 1999-11-01 AR ARP990105524A patent/AR021054A1/en unknown
-
2001
- 2001-04-30 NO NO20012133A patent/NO20012133L/en not_active Application Discontinuation
- 2001-05-02 HR HR20010311A patent/HRP20010311A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL348808A1 (en) | 2002-06-17 |
| CA2348907A1 (en) | 2000-05-11 |
| AU6422499A (en) | 2000-05-22 |
| HRP20010311A2 (en) | 2002-06-30 |
| BR9914981A (en) | 2001-10-30 |
| CN1346266A (en) | 2002-04-24 |
| WO2000025769A1 (en) | 2000-05-11 |
| NO20012133L (en) | 2001-07-02 |
| EA003557B1 (en) | 2003-06-26 |
| NO20012133D0 (en) | 2001-04-30 |
| AU763273B2 (en) | 2003-07-17 |
| EP1126834A1 (en) | 2001-08-29 |
| CZ20011535A3 (en) | 2002-08-14 |
| HUP0104260A3 (en) | 2002-11-28 |
| EA200100501A1 (en) | 2001-10-22 |
| HUP0104260A2 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022723A1 (en) | ANALGESIC COMPOUNDS THAT INCLUDE ANTIEPILEPTIC COMPOUNDS AND METHODS FOR USE | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| AR035500A1 (en) | USE OF CLORPROMAZINE AND PENTAMIDINE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL PACKAGE THAT INCLUDE CHLORPROMAZINE AND PENTAMIDINE. | |
| GEP20053539B (en) | Antidiabetic Formulation | |
| ECSP066268A (en) | MIOSTATINE INHIBITORS (GDF8) IN COMBINATION WITH CORTICOESTEROIDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | |
| NO20001175L (en) | Painkillers comprising anti-epileptic compounds and methods for their use | |
| IL158559A0 (en) | Acne treatment | |
| AU7001001A (en) | Modified forms of pharmacologically active agents and uses therefor | |
| CA2214033A1 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent | |
| UY27773A1 (en) | TRANSDERMAL ANALGESIC SYSTEMS WITH REDUCED POTENTIAL OF ABUSE. | |
| ES2177637T3 (en) | MEDICINES FOR THE TREATMENT OF RESTENOSIS, WHICH INCLUDE NITRIC OXIDE RELEASE POLYMERS. | |
| PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
| ATE427747T1 (en) | PHARMACEUTICAL FORMS CONTAINING A PROTON PUMP INHIBITOR, AN NSAID AND A BUFFER | |
| DE60215373D1 (en) | DEVICE FOR DISTRIBUTING MICRO-DOSES OF A MEDICAMENT IN THE EAR | |
| MX2007008227A (en) | Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof. | |
| TR200000755T2 (en) | Treatment of anti-oppositional disorder. | |
| NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
| IL155781A0 (en) | Effective antitumor treatments | |
| HK1073250A1 (en) | Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori | |
| CA2189916A1 (en) | A new regime for paclitaxel in kaposi's sarcoma patients | |
| AR021054A1 (en) | ANALGESIC REGIME | |
| CO5700723A2 (en) | USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY | |
| AR026254A1 (en) | THE USE OF A CONTROLLED RELEASE PREPARATION FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE THE DOSE OR SYSTEM EXPOSURE OF A PHARMACO THAT INHIBITS PHOSPHODESTERASE 4 | |
| DE60216458D1 (en) | METHOD FOR TRIGGERING A CONTINUOUS IMMUNE RESPONSE | |
| AR018321A1 (en) | A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |